Trials / Not Yet Recruiting
Not Yet RecruitingNCT03359304
The Neurofibromatosis-associated Tumor Biobank
Establishment of Neurofibromatosis-associated Tumours Biobank for Future Genomic-based Research Aiming at Improved Outcome Prediction
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Ren tingting · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research
Detailed description
Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material. Questionnaire information, including health history, growth and development, physical activity and family medical history information. If patients have been diagnosed with a neurofibromatosis-associated tumor or another condition the investigator is interested in， the investigator will ask the patient to release medical record information relating to diagnosis and treatment of neurofibromatosis-associated tumor, other cancers, blood disorders, and similar conditions.
Conditions
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2023-03-01
- Completion
- 2028-03-01
- First posted
- 2017-12-02
- Last updated
- 2017-12-02
Source: ClinicalTrials.gov record NCT03359304. Inclusion in this directory is not an endorsement.